Abstract
Total parenteral nutrition (TPN) is commonly used in the management of inflammatory bowel disease (IBD). Claims of its effectiveness are conflicting, and most reports have been limited to short-term assessments. We undertook a nonrandomized prospective study of the effects of TPN on the course of IBD in 30 patients whose disease was refractory to medical therapy, 20 with Crohn's disease and 10 with ulcerative colitis. Parameters of nutritional improvement, subjective and objective clinical response during TPN, and long-term outcome were assessed. All but one of the patients gained weight. Seven of the 20 Crohn's patients, including 3 of 4 with fistulas, had no response to TPN. The other 13 had reduction of diarrhea, relief of abdominal pain, and an improved sense of wellbeing during TPN. On long-term follow-up, five of these patients relapsed and required surgery; five remain improved with active disease controlled by medication 2–24 months later, and three are symptom-free and off all medication 20–48 months later. Clinical improvement during TPN was observed in only four of the 10 ulcerative colitis patients; six required colectomy after 9–24 days of TPN. Of the four responders, one relapsed and had colectomy one month later, two continue to have active disease controlled by medication five and 43 months later, and one has been symptom-free and off all medication for over three years. We conclude that TPN is useful adjunctive therapy for IBD patients requiring bowel rest and nutritional repletion. Dramatic clinical improvement occurs in some patients but is unpredictable.
Similar content being viewed by others
References
Fischer JE, Foster GS, Abel RM, Abbot WM, Ryan JA: Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg 125:165–175, 1973
Vogel CM, Corwin TR, Baue AE: Intravenous hyperalimentation in the treatment of inflammatory diseases of the bowel. Arch Surg 108:460–467, 1974
Dudrick SJ, MacFadyen, BV, Jr, Daly JM: Management of inflammatory bowel disease with parenteral hyperalimentation.In Gastrointestinal Emergencies, Clearfield HR, Dinoso VP (eds.). Philadelphia, Grune and Stratton, 1976, pp 193–199
Anderson DL, Boyce HW: Use of parenteral nutrition in treatment of advanced regional enteritis. Am J Dig Dis 18:633–640, 1973
Reilly J, Ryan JA, Steole W, Fischer JE: Hyperalimentation in inflammatory bowel disease. Am J Surg 131:192–200, 1976
Greenberg GR, Haber GB, Jeejeebhoy KN: Total parenteral nutrition (TPN) and bowel rest in the management of Crohn's disease. Gut 12:828, 1976
Schachter H, Kirsner JB: Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 68:591–600, 1975
Dudrick SJ, Lang JM, Steiger E, Rhoads JE: Intravenous hyperalimentation. Med Clin North Am 54:577–589, 1970
Berkovitz ZT, Kirsner JB, Lindner AE, Marshak RH, Menguy RB, Sommers SC: Ulcerative and Granulomatous Colitis. Springfield, Illinois, Charles C Thomas, 1973, p 258
Dudrick SJ, MacFadyen BV, Van Buren CT, Ruberg RL, Maynard AT: Parenteral hyperalimentation: Metabolic problems and solution. Ann Surg 176:259–264, 1972
MacFadyen BV, Dudrick SJ, Ruberg RL: Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 74:100–105, 1973
Eisenberg HW, Turnbull RB, Weakly FL: Hyperalimentation as preparation for surgery in transmural colitis (Crohn's disease). Dis Col Rect 17:469–475, 1974
MacFadyen BV, Dudrick SJ: The management of fistulae in inflammatory bowel disease with parenteral hyperalimentation.In Proc. of the Int. Congress of Parenteral Nutrition, Université de Montpellier, France, 1974, pp 559–562
Layden T, Rosenberg J, Nemchausky B, Elson C, Rosenberg I: Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterology 70:1017–1021, 1976
Author information
Authors and Affiliations
Additional information
Supported by USPHS Training Grant 1T32-AM-07074.
Rights and permissions
About this article
Cite this article
Elson, C.O., Layden, T.J., Nemchausky, B.A. et al. An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Digest Dis Sci 25, 42–48 (1980). https://doi.org/10.1007/BF01312731
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01312731